Suppr超能文献

血管升压素生理浓度对大鼠肾功能的急性影响。

Acute effect of physiological concentrations of vasopressin on rat renal function.

作者信息

Carney S L, Gillies A H, Ray C D

机构信息

Faculty of Medicine, University of Newcastle, New South Wales, Australia.

出版信息

Clin Exp Pharmacol Physiol. 1993 Feb;20(2):113-9. doi: 10.1111/j.1440-1681.1993.tb00583.x.

Abstract
  1. The antidiuretic, pressor and electrolyte transport effects of arginine vasopressin (AVP) were simultaneously evaluated in the anaesthetized water diuretic rat. Increasing concentrations of AVP (7.5, 75 and 750 ng/kg bolus and per h), were used to produce plasma levels which approximate the physiological range (408 +/- 2.4, 35.7 +/- 12.5, 85.2 +/- 16.1 pg/mL respectively). 2. Administration of a minimally effective antidiuretic dose (7.5 ng) increased mean urine osmolality (from 101 +/- 7 to 312 +/- 89 mosmol/kg) without altering mean arterial pressure (MAP), renal plasma flow (RPF) or glomerular filtration rate (GFR). A maximal antidiuretic dose of AVP (75 ng) increased mean urine osmolality to 2002 +/- 109 mosmol/kg and was associated with significant mean increases in MAP (9 mmHg), RPF and GFR (25%) by 30-60 min. A further ten-fold increase in AVP (750 ng) produced a greater increase in MAP (116 +/- 6 to 134 +/- 7 mmHg; P < 0.01) as well as increasing RPF and GFR by 35.5 and 38.9% respectively. 3. Increasing concentrations of AVP also progressively increased the fractional excretion of sodium, potassium and phosphate. However, fractional calcium and magnesium excretion was significantly decreased with maximal and supramaximal concentrations. 4. These studies support evidence that AVP is a pressor hormone in physiological concentrations in baroreceptor intact animals. Its role in renal electrolyte transport is unclear. Measured increases in RPF and GFR with the maximal and supramaximal AVP concentrations appear to be correlated with the increase in MAP.
摘要
  1. 在麻醉的水利尿大鼠中,同时评估了精氨酸加压素(AVP)的抗利尿、升压和电解质转运作用。使用递增浓度的AVP(静脉推注和每小时7.5、75和750 ng/kg),使血浆水平接近生理范围(分别为408±2.4、35.7±12.5、85.2±16.1 pg/mL)。2. 给予最小有效抗利尿剂量(7.5 ng)可增加平均尿渗透压(从101±7至312±89 mosmol/kg),而不改变平均动脉压(MAP)、肾血浆流量(RPF)或肾小球滤过率(GFR)。最大抗利尿剂量的AVP(75 ng)可使平均尿渗透压增加至2002±109 mosmol/kg,并在30 - 60分钟时导致MAP(9 mmHg)、RPF和GFR显著平均增加(25%)。AVP进一步增加10倍(750 ng)会使MAP有更大幅度增加(从116±6至134±7 mmHg;P < 0.01),同时RPF和GFR分别增加35.5%和38.9%。3. 递增浓度的AVP也逐渐增加钠、钾和磷酸盐的分数排泄。然而,最大和超最大浓度时钙和镁的分数排泄显著降低。4. 这些研究支持以下证据:在压力感受器完整的动物中,生理浓度的AVP是一种升压激素。其在肾电解质转运中的作用尚不清楚。最大和超最大AVP浓度下测量到的RPF和GFR增加似乎与MAP的增加相关。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验